Supplementary Data 1 from A Phase II Study of Acimtamig (AFM13) in Patients with CD30-Positive, Relapsed, or Refractory Peripheral T-cell LymphomasWon Seog Kim,Jake Shortt,Pier Luigi Zinzani,Natalia Mikhailova,Dejan Radeski,Vincent Ribrag,Eva Domingo Domenech,Ahmed Sawas,Karenza Alexis,Michael Emig, Riham Elbadri, Pallavi Hajela,Paulien Ravenstijn,Sheena Pinto, Linta Garcia,Andre Overesch,Kerstin Pietzko,Steven Horwitzcrossref（2025）引用 0|浏览1AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
